Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial
- DOI
- 10.1038/s41591-026-04559-4
- Published
- 2026-09
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04559-4,
title = {Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial},
author = {Xinghao Ai and Zhengbo Song and Lin Wu and Aiping Zhou and Di Cheng and Hong Zong and Heshui Wu and Zuoxing Niu and Yuping Sun and Lingjun Zhu and Zhiwei Li and Yanhong Deng and Ying Yuan and Xiujuan Qu and Haitao Zhao and Yingying Du and Ziming Li and Yu Wang and Haige Shen and Huaqiang Zhu and Chanli Zheng and Shuang Wang and Zhao Cui and Lingyu Tai and Shun Lu},
year = {2026},
journal = {Nature Medicine},
doi = {10.1038/s41591-026-04559-4},
url = {https://doi.org/10.1038/s41591-026-04559-4}
}RIS
TY - JOUR TI - Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial AU - Xinghao Ai AU - Zhengbo Song AU - Lin Wu AU - Aiping Zhou AU - Di Cheng AU - Hong Zong AU - Heshui Wu AU - Zuoxing Niu AU - Yuping Sun AU - Lingjun Zhu AU - Zhiwei Li AU - Yanhong Deng AU - Ying Yuan AU - Xiujuan Qu AU - Haitao Zhao AU - Yingying Du AU - Ziming Li AU - Yu Wang AU - Haige Shen AU - Huaqiang Zhu AU - Chanli Zheng AU - Shuang Wang AU - Zhao Cui AU - Lingyu Tai AU - Shun Lu PY - 2026 JO - Nature Medicine DO - 10.1038/s41591-026-04559-4 UR - https://doi.org/10.1038/s41591-026-04559-4 ER -
APA
Ai, X., Song, Z., Wu, L., Zhou, A., Cheng, D., Zong, H., Wu, H., Niu, Z., Sun, Y., Zhu, L., Li, Z., Deng, Y., Yuan, Y., Qu, X., Zhao, H., Du, Y., Li, Z., Wang, Y., Shen, H., Zhu, H., Zheng, C., Wang, S., Cui, Z., Tai, L., & Lu, S. (2026). Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04559-4
Source records
- crossref · retrieved 2026-09-26T04:16:49.282Z